Key result
Transplant pharmacist discharge reconciliation linked to ~68% fewer medication errors at first clinic visit.
Why the study?
Solid-organ transplant recipients are at increased risk for medication errors during transitions of care, particularly at discharge, necessitating evaluation of pharmacist involvement to improve safety.
Does transplant pharmacist involvement reduce medication errors at discharge in solid-organ transplant recipients?
Comparison
Transplant pharmacist involvement vs no pharmacist involvement at discharge
Design
Prospective observational study with historical control
Follow-up
Until first clinic visit
Authors
Loading...
May reduce discharge medication errors in transplant recipients; leaves open need for randomized trials on clinical outcomes.
Observational (n=192)
Does transplant pharmacist involvement reduce medication errors at discharge in solid-organ transplant recipients?
Absolute Event Rate: 1.1% vs 3.4%
p-value: p=<0.0001
Transplant pharmacist involvement in discharge medication reconciliation significantly reduces medication errors in solid-organ transplant recipients.
Musgrave et al. (2013) conducted an observational in Solid-organ transplant (n=192). Transplant pharmacist discharge medication reconciliation vs. Historical control group was evaluated on Medication errors persisting until the first clinic visit (p=<0.0001). Transplant pharmacist discharge medication reconciliation reduced medication errors persisting until the first clinic visit compared to historical controls (1.1 vs 3.4 errors per patient, p<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: